open access
Endovascular embolization as a treatment for symptomatic adenomyosis — results of preliminary study
Affiliations- Department of Interventional Radiology and Neuroradiology, Medical University of Lublin, Poland
- Department of Endocrinology, Medical University in Lublin, Poland
- Semmelweis University, Department of Radiology, Hungary, Hungary
- Departament of Radiology, Medicover Hospital in Warsaw, Poland
- 3rd Chair and Department of Gynecology, Medical University in Lublin, Poland
open access
Abstract
Objectives: To present preliminary results of minimally invasive endovascular embolization as a treatment of symptomatic adenomyosis or adenomyosis with fibroids and to assess the long-term clinical outcome.
Material and methods: Between 2015 and 2020 twelve patients with symptomatic adenomyosis or adenomyosis with fibroids underwent uterine artery embolization (UAE). All patients were evaluated in terms of patient’s overall satisfaction, relief of clinical symptoms, reintervention and hysterectomy as well as menopause rates.
Results: Mean age on admission was 48 years. Reported symptoms included: dysmenorrhea with the mean VAS score of 7.8, menorrhagia and problems with urination. Successful embolization was achieved in all patients (100%). A reduction in pelvic pain intensity assessed using VAS was observed in 11/12 (92%) of the patients — pain decreased by 6.2 points on average (from 7.8 to 1.6 pts). In one patient (8%) the recurrence of pain was observed. All patients reported decrease of menstrual bleeding and consequently improvement of everyday life quality. Avoidance of hysterectomy was achieved in 83% of the women. Five patients experience absence of menstrual periods for at least 12 months after the embolization resulting in menopause rate of 42%. Ten patients (83%) reported to be very or fairly satisfied with the results and would recommend this treatment to a friend.
Conclusions: Uterine artery embolization might be safe and effective method of treatment for patients with symptomatic adenomyosis with or without fibroids with very high rate of satisfied patients.
Abstract
Objectives: To present preliminary results of minimally invasive endovascular embolization as a treatment of symptomatic adenomyosis or adenomyosis with fibroids and to assess the long-term clinical outcome.
Material and methods: Between 2015 and 2020 twelve patients with symptomatic adenomyosis or adenomyosis with fibroids underwent uterine artery embolization (UAE). All patients were evaluated in terms of patient’s overall satisfaction, relief of clinical symptoms, reintervention and hysterectomy as well as menopause rates.
Results: Mean age on admission was 48 years. Reported symptoms included: dysmenorrhea with the mean VAS score of 7.8, menorrhagia and problems with urination. Successful embolization was achieved in all patients (100%). A reduction in pelvic pain intensity assessed using VAS was observed in 11/12 (92%) of the patients — pain decreased by 6.2 points on average (from 7.8 to 1.6 pts). In one patient (8%) the recurrence of pain was observed. All patients reported decrease of menstrual bleeding and consequently improvement of everyday life quality. Avoidance of hysterectomy was achieved in 83% of the women. Five patients experience absence of menstrual periods for at least 12 months after the embolization resulting in menopause rate of 42%. Ten patients (83%) reported to be very or fairly satisfied with the results and would recommend this treatment to a friend.
Conclusions: Uterine artery embolization might be safe and effective method of treatment for patients with symptomatic adenomyosis with or without fibroids with very high rate of satisfied patients.
Keywords
uterine artery embolization; adenomyosis; long-term results; minimally invasive
About this articleTitle
Endovascular embolization as a treatment for symptomatic adenomyosis — results of preliminary study
Journal
Issue
Article type
Research paper
Pages
273-277
Published online
2021-07-06
Page views
5385
Article views/downloads
902
DOI
Pubmed
Bibliographic record
Ginekol Pol 2022;93(4):273-277.
Keywords
uterine artery embolization
adenomyosis
long-term results
minimally invasive
Authors
Krzysztof Pyra
Maciej Szmygin
Hanna Szmygin
Viktor Bèrczi
Rafal Kidzinski
Tomasz Jargiello
Tomasz Paszkowski
Slawomir Wozniak
References (25)- Struble J, Reid S, Bedaiwy MA. Adenomyosis: A Clinical Review of a Challenging Gynecologic Condition. J Minim Invasive Gynecol. 2016; 23(2): 164–185.
- Yu O, Schulze-Rath R, Grafton J, et al. Adenomyosis incidence, prevalence and treatment: United States population-based study 2006-2015. Am J Obstet Gynecol. 2020; 223(1): 94.e1–94.e10.
- McElin TW, Bird CC. Adenomyosis of the uterus. Obstet Gynecol Annu. 1974; 3: 425–441.
- Chapron C, Vannuccini S, Santulli P, et al. Diagnosing adenomyosis: an integrated clinical and imaging approach. Hum Reprod Update. 2020; 26(3): 392–411.
- Pinzauti S, Lazzeri L, Tosti C, et al. Transvaginal sonographic features of diffuse adenomyosis in 18-30-year-old nulligravid women without endometriosis: association with symptoms. Ultrasound Obstet Gynecol. 2015; 46(6): 730–736.
- Abbott JA. Adenomyosis and Abnormal Uterine Bleeding (AUB-A)-Pathogenesis, diagnosis, and management. Best Pract Res Clin Obstet Gynaecol. 2017; 40: 68–81.
- Marjoribanks J, Proctor ML, Farquhar C. Nonsteroidal anti-inflammatory drugs for primary dysmenorrhoea. Cochrane Database Syst Rev. 2003(4): CD001751.
- Farquhar C, Brosens I. Medical and surgical management of adenomyosis. Best Pract Res Clin Obstet Gynaecol. 2006; 20(4): 603–616.
- Zhou M, Chen JY, Tang LD, et al. Ultrasound-guided high-intensity focused ultrasound ablation for adenomyosis: the clinical experience of a single center. Fertil Steril. 2011; 95(3): 900–905.
- Kim KAh, Yoon SW, Lee C, et al. Short-term results of magnetic resonance imaging-guided focused ultrasound surgery for patients with adenomyosis: symptomatic relief and pain reduction. Fertil Steril. 2011; 95(3): 1152–1155.
- Smeets AJ, Nijenhuis RJ, Boekkooi PF, et al. Long-term follow-up of uterine artery embolization for symptomatic adenomyosis. Cardiovasc Intervent Radiol. 2012; 35(4): 815–819.
- de Bruijn AM, Smink M, Hehenkamp WJK, et al. Uterine Artery Embolization for Symptomatic Adenomyosis: 7-Year Clinical Follow-up Using UFS-Qol Questionnaire. Cardiovasc Intervent Radiol. 2017; 40(9): 1344–1350.
- Ascher SM, Arnold LL, Patt RH, et al. Adenomyosis: prospective comparison of MR imaging and transvaginal sonography. Radiology. 1994; 190(3): 803–806.
- Wood C. Surgical and medical treatment of adenomyosis. Hum Reprod Update. 1998; 4(4): 323–336.
- Siskin GP, Tublin ME, Stainken BF, et al. Uterine artery embolization for the treatment of adenomyosis: clinical response and evaluation with MR imaging. AJR Am J Roentgenol. 2001; 177(2): 297–302.
- Kim MD, Won JW, Lee DY, et al. Uterine artery embolization for adenomyosis without fibroids. Clin Radiol. 2004; 59(6): 520–526.
- Jha RC, Takahama J, Imaoka I, et al. Adenomyosis: MRI of the uterus treated with uterine artery embolization. AJR Am J Roentgenol. 2003; 181(3): 851–856.
- Pelage JP, Jacob D, Fazel A, et al. Midterm results of uterine artery embolization for symptomatic adenomyosis: initial experience. Radiology. 2005; 234(3): 948–953.
- Kim MD, Kim S, Kim NK, et al. Long-term results of uterine artery embolization for symptomatic adenomyosis. AJR Am J Roentgenol. 2007; 188(1): 176–181.
- Bae SH, Kim MD, Kim GM, et al. Uterine Artery Embolization for Adenomyosis: Percentage of Necrosis Predicts Midterm Clinical Recurrence. J Vasc Interv Radiol. 2015; 26(9): 1290–6.e2.
- Haefeli M, Elfering A. Pain assessment. Eur Spine J. 2006; 15 Suppl 1: S17–S24.
- Wood C. Surgical and medical treatment of adenomyosis. Hum Reprod Update. 1998; 4(4): 323–336.
- Litta P, Nappi L, Florio P, et al. Proposal of a modified transcervical endometrial resection (TCER) technique for menorrhagia treatment. Feasibility, efficacy, and patients’ acceptability. Gynecol Surg. 2014; 11(3): 165–171.
- Kaump GR, Spies JB. The impact of uterine artery embolization on ovarian function. J Vasc Interv Radiol. 2013; 24(4): 459–467.
- Treloar AE. Menstrual cyclicity and the pre-menopause. Maturitas. 1981; 3(3-4): 249–264.
